삼중음성유방암에서 Foxp3 양성 조절 T세포와 종양 침윤 T림프구의 의의
Significance of Foxp3 Positive Regulatory T Cell and Tumor Infiltrating T Lymphocyte in Triple Negative Breast Cancer
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Triple negative breast cancer (TNBC) is defined as a lack of the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer. Many TNBCs show a profound infiltration of tumor infiltrating lymphocytes (TILs). It is still uncertain whether these TILs are protumoral or antitumoral. Regulatory T cells (Tregs) play a role in inducing immune tolerance to antigens, and they may be selectively recruited by cancer cells. This study was conducted to evaluate the significance of TILs with an emphasis on forkhead box p3 (Foxp3), which is a marker for CD25+CD4+ Treg in TNBC. Methods: We investigated the Foxp3, CD8 and CD4 expressions in 100 cases of TNBC by immunohistochemistry and using a tissue microarray. The Foxp3 expression was divided as the high and low infiltration groups (cut-off value=20). Results: The high infiltration group was correlated with higher histologic and nuclear grades. However, Foxp3+ Tregs were decreased in the T3 and T4 TNBCs as compared to that of the T1 and T2 TNBCs. No significant differences were found for the nodal status, lymphovascular invasion, stage, recurrence and overall survival. Conclusions: High Foxp3+ Treg infiltration in TNBC is correlated with the nuclear and histologic grades, but there was no relation to recurrence and overall survival.
Abstract
Background: Triple negative breast cancer (TNBC) is defined as a lack of the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer. Many TNBCs show a profound infiltration of tumor infiltrating lymphocytes (TILs). It is still uncertain whether these TILs are protumoral or antitumoral. Regulatory T cells (Tregs) play a role in inducing immune tolerance to antigens, and they may be selectively recruited by cancer cells. This study was conducted to evaluate the significance of TILs with an emphasis on forkhead box p3 (Foxp3), which is a marker for CD25+CD4+ Treg in TNBC. Methods: We investigated the Foxp3, CD8 and CD4 expressions in 100 cases of TNBC by immunohistochemistry and using a tissue microarray. The Foxp3 expression was divided as the high and low infiltration groups (cut-off value=20). Results: The high infiltration group was correlated with higher histologic and nuclear grades. However, Foxp3+ Tregs were decreased in the T3 and T4 TNBCs as compared to that of the T1 and T2 TNBCs. No significant differences were found for the nodal status, lymphovascular invasion, stage, recurrence and overall survival. Conclusions: High Foxp3+ Treg infiltration in TNBC is correlated with the nuclear and histologic grades, but there was no relation to recurrence and overall survival.
참고문헌 (30)
- Denkert C, "Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer", J Clin Oncol, 28, pp.105~113 (2010)
- Bohling SD, "Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target", Mod Pathol, 21, pp.1527~1532 (2008)
- Kuroda H, "Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast", Virchows Arch, 446, pp.10~14 (2005)
- Perou CM, "Molecular portraits of human breast tumours", Nature, 406, pp.747~752 (2000)
- Sorlie T, "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications", Proc Natl Acad Sci USA, 98, pp.10869~10874 (2001)
- Sorlie T, "Repeated observation of breast tumor subtypes in independent gene expression data sets", Proc Natl Acad Sci USA, 100, pp.8418~8423 (2003)
- Rakha EA, "Triple-negative", basal-like breast cancer: review, 2009, pp.41, 40~47
- Rakha EA, "Prognostic markers in triple-negative breast cancer", Cancer, 109, pp.25~32 (2007)
- Carey LA, "Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study", JAMA, 295, pp.2492~2502 (2006)
- Reis-Filho JS, "Triple negative tumours: a critical review", Histopathology, 52, pp.108~118 (2008)
- 이경근, "삼중음성유방암과 비삼중음성유방암의 임상병리학적 특성의 비교", 대한외과학회지, 79(1), pp.14~19 (2010), 대한외과학회
- 이정훈, "면역조직화학적 염색에 의해 분류한 유방암 기저형과 내강형의 생존율 분석", 대한외과학회지, 70(1), pp.7~13 (2006), 대한외과학회
- 이선아, "유방의 화생성 편평상피세포암종 17예에 대한 임상 및 병리학적 분석", The Korean Journal of Pathology, 43(1), pp.20~25 (2009), 대한병리학회
- 조민선, "자연 경과에 따른 만성 B형 간염의 간조직 내 FoxP3 양성 조절 T세포의 침윤 양상: 간 침생검 조직을 이용한 면역 조직 화학적 연구", The Korean Journal of Pathology, 44(2), pp.132~140 (2010), 대한병리학회
- Curiel TJ, "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival", Nat Med, 10, pp.942~949 (2004)
- 장규윤, "The Prognostic Significance of the Tumor-Infiltrating FoxP3-Positive Regulatory T Cells in Gastric Carcinoma", The Korean Journal of Pathology, 44(1), pp.9~15 (2010), 대한병리학회
- Bates GJ, "Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse", J Clin Oncol, 24, pp.5373~5380 (2006)
- Generali D, "Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients", Clin Cancer Res, 15, pp.1046~1051 (2009)
- Sakaguchi S, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of selftolerance causes various autoimmune diseases", J Immunol, 155, pp.1151~1164 (1995)
- Takahashi T, "Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4", J Exp Med, 192, pp.303~310 (2000)
- Hori S, "Control of regulatory T cell development by the transcription factor Foxp3", Science, 299, pp.1057~1061 (2003)
- Jonuleit H, "The regulatory T cell family: distinct subsets and their interrelations", J Immunol, 171, pp.6323~6327 (2003)
- Harvey JM, "Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer", J Clin Oncol, 17, pp.1474~1481 (1999)
- Burnet FM, "The concept of immunological surveillance", Prog Exp Tumor Res, 13, pp.1~27 (1970)
- Dunn GP, "Cancer immunoediting: from immunosurveillance to tumor escape", Nat Immunol, 3, pp.991~998 (2002)
- Dunn GP, "Interferons, immunity and cancer immunoediting", Nat Rev Immunol, 6, pp.836~848 (2006)
- Curiel TJ, "Tregs and rethinking cancer immunotherapy", J Clin Invest, 117, pp.1167~1174 (2007)
- Desar IM, "Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients", Int J Cancer (2010)
- Loddenkemper C, "Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer", Cancer Sci, 100, pp.1112~1117 (2009)
- Ladoire S, "Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells", Clin Cancer Res, 14, pp.2413~2420 (2008)